{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:52:27Z","timestamp":1782485547577,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clml.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T01:57:59Z","timestamp":1611539879000},"page":"328-337.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL\u2013Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia"],"prefix":"10.1016","volume":"21","author":[{"given":"Lara Maria","family":"G\u00f3mez Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Fuster Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia Pascual","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Vagace Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7215-9403","authenticated-orcid":false,"given":"Beatriz","family":"Ruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5774-8904","authenticated-orcid":false,"given":"Alfonso","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-9002","authenticated-orcid":false,"given":"Alejandra","family":"Leivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ferreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"De Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Blanquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Sisinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-4590","authenticated-orcid":false,"given":"Isabel","family":"Mirones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Borobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.01.013_bib1","first-page":"127","article-title":"Pediatric AML: from biology to clinical management","volume":"4","author":"de Rooij","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clml.2021.01.013_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.013_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bjh.12900","article-title":"A\u00a0critical review of which children with acute myeloid leukaemia need stem cell procedures","volume":"166","author":"Hasle","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.01.013_bib4","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","volume":"12","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.013_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/children7020012","article-title":"New and emerging targeted therapies for pediatric acute myeloid leukemia (AML)","volume":"7","author":"Chen","year":"2020","journal-title":"Children"},{"key":"10.1016\/j.clml.2021.01.013_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11912-019-0837-8","article-title":"The role of natural killer cells as a platform for immunotherapy in pediatric cancers","volume":"21","author":"Kimpo","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clml.2021.01.013_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000365632","article-title":"Human natural killer cells: origin, receptors, function, and clinical applications","volume":"164","author":"Moretta","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clml.2021.01.013_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anpedi.2015.07.004","article-title":"[An immunological approach to acute myeloid leukaemia]","volume":"84","author":"Gonz\u00e1lez","year":"2016","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.clml.2021.01.013_bib9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell\u00a0alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clml.2021.01.013_bib10","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand\u2013mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.013_bib11","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/1078-0432.CCR-15-1604","article-title":"Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients","volume":"22","author":"Curti","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2021.01.013_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bbmt.2018.03.019","article-title":"A\u00a0phase 1 trial of CNDO-109\u2013activated natural killer cells in patients with high-risk acute myeloid leukemia","volume":"24","author":"Fehniger","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.013_bib13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbmt.2018.06.019","article-title":"Primed to kill: CTV-1 stimulated haploidentical natural killer cells for consolidation of AML","volume":"24","author":"Doherty","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.013_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2015.12.028","article-title":"Phase II study of haploidentical natural killer cell infusion for treatment of relapsed or persistent myeloid malignancies following allogeneic hematopoietic cell transplantation","volume":"22","author":"Shaffer","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.013_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2021.01.013_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40425-019-0564-6","article-title":"A\u00a0phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia","volume":"20","author":"Nguyen","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.clml.2021.01.013_bib17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbmt.2016.04.009","article-title":"Haploidentical natural killer cells infused before allogeneic stem cell transplantation for myeloid malignancies: a phase I trial","volume":"22","author":"Lee","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.013_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jcyt.2015.07.011","article-title":"A\u00a0phase I\/II trial of interleukin-15\u2014stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors","volume":"17","author":"P\u00e9rez-Mart\u00ednez","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.clml.2021.01.013_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2018.02.033","article-title":"Haploidentical IL-15\/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia","volume":"422","author":"Vela","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clml.2021.01.013_bib20","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/trf.14573","article-title":"How do we manufacture clinical-grade interleukin-15\u2013stimulated natural killer cell products for cancer treatment?","volume":"58","author":"Fern\u00e1ndez","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.clml.2021.01.013_bib21","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3389\/fimmu.2019.01814","article-title":"Anti-CXCR4 antibody combined with activated and expanded natural killer cells for sarcoma immunotherapy","volume":"10","author":"Vela","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clml.2021.01.013_bib22","doi-asserted-by":"crossref","first-page":"e029642","DOI":"10.1136\/bmjopen-2019-029642","article-title":"Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia","volume":"10","author":"Mu\u00f1oz Builes","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.clml.2021.01.013_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","article-title":"Use of NK cell activity in cure by transplant","volume":"155","author":"Leung","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.01.013_bib24","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.013_bib25","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood-2008-01-135285","article-title":"Survival after T cell\u2013depleted haploidentical stem cell transplantation is improved using the mother as donor","volume":"112","author":"Stern","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.013_bib26","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.2019000982","article-title":"IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia","volume":"134","author":"Gonz\u00e1lez-Garc\u00eda","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.013_bib27","first-page":"46","article-title":"Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings","volume":"13","author":"Ishid","year":"2020","journal-title":"Biomed Rep"},{"key":"10.1016\/j.clml.2021.01.013_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions","volume":"24","author":"Bolouri","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.clml.2021.01.013_bib29","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clml.2021.01.013_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A\u00a0framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.clml.2021.01.013_bib32","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.clml.2021.01.013_bib33","article-title":"Calling somatic SNVs and indels with Mutect2","author":"Benjamin","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.clml.2021.01.013_bib34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/bioinformatics\/bty849","article-title":"Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data","volume":"35","author":"Dunn","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clml.2021.01.013_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A\u00a0program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118, iso-2, iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.clml.2021.01.013_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10428194.2017.1361025","article-title":"KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia","volume":"59","author":"Chen","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.01.013_bib37","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1038\/s41586-019-1475-x","article-title":"Publisher correction: absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.clml.2021.01.013_bib38","first-page":"1","article-title":"The emerging role of immune checkpoint based approaches in AML and MDS","volume":"59","author":"Boddu","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.01.013_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.clml.2021.01.013_bib40","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/cncr.31896","article-title":"The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia","volume":"125","author":"Williams","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2021.01.013_bib41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/14712598.2015.1051028","article-title":"Programmed death-1 checkpoint blockade in acute myeloid leukemia","volume":"15","author":"Sehgal","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.clml.2021.01.013_bib42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/07853890.2016.1186827","article-title":"Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies","volume":"48","author":"Tsirigotis","year":"2016","journal-title":"Ann Med"},{"key":"10.1016\/j.clml.2021.01.013_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion","volume":"56","author":"Blank","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clml.2021.01.013_bib44","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood-2013-11-536219","article-title":"c-Myc regulates expression of NKG2D ligands ULBP1\/2\/3 in AML and modulates their susceptibility to NK-mediated lysis","volume":"123","author":"Nanbakhsh","year":"2014","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:36:17Z","timestamp":1761870977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2152265021000215"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL\u2013Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}